Skip to main content

Tomorrow Investor

Press Release
SAGA Metals Reports Assays from R-0064 to R-0071 with Intercepts Including 52.52% Fe2O3, 7.58% TiO2, 0.428% V2O5 from 2026 Drilling at Radar Critical Minerals Project in Labrador
SAGA Metals Reports Significant Assay Results from 2026 Drilling | Newsfile Corp Source: Newsfile Corp • Published: March 15, 2024 • Sentiment: positive • Ticker: SAGMF Vancouver, British Columbia–(Newsfile Corp. – September 10, 2026) – SAGA Metals Corp. (TSXV: SAGA) (OTCQX:...
Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247
Satellos Unveils Forazapadin as New Drug Name for SAT-3247 | GlobeNewsWire Source: GlobeNewsWire...
Draganfly Appoints Colonel (Ret'd) Kevin Leblond to Lead Canadian Defence and Security Initiatives
Draganfly Hires Colonel (Ret’d) Kevin Leblond for Defence Role | GlobeNewsWire Source: GlobeNewsWire...
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
FDA Greenlights Quantum BioPharma's Historic MS Treatment Trials | GlobeNewsWire Source: GlobeNewsWire...
RETRANSMISSION: Prospect Markets Executes Definitive Agreement with Crypto.com, Targeting U.S. Market Exceeding $1 Trillion in Annual Trading Volume
Prospect Markets Partners with Crypto.com for U.S. Prediction Market | Newsfile Corp Source: Newsfile...
SAGA Metals Commences Diamond Drilling at the Wolverine Heavy Rare Earth Element Project in Labrador - First Two Diamond Drill Holes Intersected Prospective REE-Bearing Volcanic Unit
SAGA Metals Launches Drilling Project in Labrador – REE Focus | Newsfile Corp Source: Newsfile...
Satellos to Participate in Upcoming Investor Conferences
Upcoming Investor Conferences: Satellos Bioscience's Key Participation | GlobeNewsWire Source: GlobeNewsWire...

Trending

AI talent retention risk illustration
Meta's AI Gamble Loses Key Talent Rapidly
pharma pipeline shift illustration
Blackstone Eyes $2B ZO Skin Health Sale
pharma pipeline shift illustration
Novartis Hit by Major Neuromuscular Drug Setback

CATEGORIES

SIGNUP TO OUR NEWSLETTER

Subscribe

Get breaking market insights directly to your inbox